Singapore Dental Biomaterials Market Size, Share, and COVID-19 Impact Analysis, By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Composites Biomaterials, Natural Biomaterials, Metal-Ceramic Biomaterials, and Others), By Application (Orthodontics, Implantology, Prosthodontics, and Others), and Singapore Dental Biomaterials Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSingapore Dental Biomaterials Market Insights Forecasts to 2035
- The Singapore Dental Biomaterials Market Size Was Estimated at USD 13.02 Million in 2024
- The Singapore Dental Biomaterials Market Size is Expected to Grow at a CAGR of Around 10.02% from 2025 to 2035
- The Singapore Dental Biomaterials Market Size is Expected to Reach USD 37.21 Million by 2035

Get more details on this report -
Market Overview
The Singapore dental biomaterials market refers to the industry involved in the production, distribution, and application of materials used in dental treatments for restoration, repair, and replacement of teeth. It includes biocompatible materials such as dental implants, ceramics, composites, alloys, adhesives, and cements, which are used in procedures like fillings, crowns, bridges, dentures, and orthodontics. These materials support functional, aesthetic, and long-lasting dental solutions and are supplied to dental clinics, hospitals, and specialized dental laboratories across Singapore.
Singapore’s adoption of the dental biomaterials market is strongly influenced by population health trends and the rising prevalence of oral diseases. According to the Singapore Ministry of Health, about 90% of adults and 60% of children experience dental issues such as caries, tooth loss, or gum disease, highlighting the urgent need for advanced dental care solutions. Growing awareness of cosmetic dentistry and preventive oral health is further driving the adoption of biocompatible materials, including ceramics, composites, dental implants, and adhesives, across both private and public dental clinics.
Government support reinforces market growth. Initiatives like the Oral Health Promotion Programme and Community Health Assist Scheme (CHAS) provide subsidies and awareness campaigns, making restorative and preventive dental care more accessible. Additionally, Singapore invests in dental research and innovation through funding from the National Medical Research Council (NMRC) and programs under the Agency for Science, Technology and Research, with allocations of over SUsd10 million annually for healthcare and biomaterials research. These policies and programs not only improve oral health outcomes but also encourage the adoption and expansion of dental biomaterials, making Singapore a strategic and growing market for dental restorative and cosmetic solutions.
Report Coverage
This research report categorizes the market for the Singapore dental biomaterials market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore dental biomaterials market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore dental biomaterials market.
Singapore Dental Biomaterials Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 13.02 Million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR of 10.02% |
| 2035 Value Projection: | USD 37.21 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 115 |
| Segments covered: | By Type, By Application |
| Companies covered:: | Dentsply Sirona, Straumann Holding AG, Zimmer Biomet Holdings, Inc., 3M Company, Danaher Corporation, Ivoclar Vivadent AG, GC Corporation, Kuraray Co., Ltd., Henry Schein, Inc., Mitsui Chemicals, Inc., Coltene Holding AG, Nobel Biocare, Others, and Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The Singapore dental biomaterials market is driven by rising dental disease prevalence, growing demand for cosmetic and restorative procedures, and technological advancements in biocompatible materials. Expansion of dental clinics, government support, and dental tourism further boost market growth.
Restraining Factors
The Singapore dental biomaterials market is restrained by the high cost of advanced materials and dental procedures, limited insurance coverage for certain cosmetic treatments, and stringent regulatory requirements for approval and safety. Additionally, lack of awareness among some patients and competition from traditional restorative methods may slow adoption.
Market Segmentation
The Singapore dental biomaterials market share is classified into type and application.
- The ceramic biomaterials segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Singapore dental biomaterials market is segmented by type into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, composite biomaterials, natural biomaterials, metal-ceramic biomaterials, and others. Among these, the ceramic biomaterials segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The ceramic biomaterials segment is growing because of its high biocompatibility, aesthetic appeal, and durability, making it ideal for dental crowns, bridges, and veneers. Increasing demand for natural-looking restorations and advanced cosmetic dental procedures in Singapore further drives the adoption of ceramic biomaterials.
- The orthodontics segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.
The Singapore dental biomaterials market is segmented by application into orthodontics, implantology, prosthodontics, and others. Among these, the orthodontics segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The orthodontics segment is growing because of the increasing demand for teeth alignment and corrective dental treatments, rising awareness of aesthetic and functional dental care, and the popularity of modern braces and clear aligners in Singapore, driving strong adoption of dental biomaterials in orthodontic applications.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Singapore dental biomaterials market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Dentsply Sirona
- Straumann Holding AG
- Zimmer Biomet Holdings, Inc.
- 3M Company
- Danaher Corporation
- Ivoclar Vivadent AG
- GC Corporation
- Kuraray Co., Ltd.
- Henry Schein, Inc.
- Mitsui Chemicals, Inc.
- Coltene Holding AG
- Nobel Biocare
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Singapore, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Singapore dental biomaterials market based on the below-mentioned segments:
Singapore Dental Biomaterials Market, By Type
- Metallic Biomaterials
- Ceramic Biomaterials
- Polymeric Biomaterials
- Composites Biomaterials
- Natural Biomaterials
- Metal-Ceramic Biomaterials
- Others
Singapore Dental Biomaterials Market, By Application
- Orthodontics
- Implantology
- Prosthodontics
- Others
Frequently Asked Questions (FAQ)
-
1.What is the Singapore dental biomaterials market size in 2024?The Singapore dental biomaterials market size was estimated at USD 13.02 million in 2024.
-
2.What is the projected market size of the Singapore dental biomaterials market by 2035?The Singapore dental biomaterials market size is expected to reach USD 37.21 million by 2035.
-
3.What is the CAGR of the Singapore dental biomaterials market?The Singapore dental biomaterials market size is expected to grow at a CAGR of around 10.02% from 2024 to 2035.
-
4.What are the key growth drivers of the Singapore dental biomaterials market?The Singapore dental biomaterials market is driven by increasing dental disease prevalence, rising demand for cosmetic and restorative procedures, and growing awareness of oral health. Advancements in biocompatible materials, expanding dental clinics, and government support further boost market growth.
-
5.Which application segment dominated the market in 2024?The orthodontics segment dominated the market in 2024.
-
6.What segments are covered in the Singapore dental biomaterials market report?The Singapore dental biomaterials market is segmented on the basis of type and application.
-
7.Who are the key players in the Singapore dental biomaterials market?Key companies include Dentsply Sirona, Straumann Holding AG, Zimmer Biomet Holdings, Inc., 3M Company, Danaher Corporation, Ivoclar Vivadent AG, GC Corporation, Kuraray Co., Ltd., Henry Schein, Inc., Mitsui Chemicals, Inc., Coltene Holding AG, Nobel Biocare, and others.
-
8.Who are the target audiences for this market report?The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?